We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01156584
Recruitment Status : Active, not recruiting
First Posted : July 5, 2010
Last Update Posted : November 15, 2016
Information provided by (Responsible Party):
Tocagen Inc.